We applied integrated profiling, including RNA-seq and Thermal proteome, that found pioneer factor Forkhead Box Protein A1 (FOXA1) and Non-homologous End Joining (NHEJ) repair executer Ku70/Ku80 were strongly suggested as the direct target of ivermectin in prostate cancer. The gene discussed is FOXA1; the disease is prostate carcinoma.